MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
Abstract Natural killer group 2 member D ligands (NKG2DLs) are expressed as stress response proteins in cancer cells. NKG2DLs induce immune cell activation or tumor escape responses, depending on their expression. Human pancreatic cancer cells, PANC-1, express membrane MHC class I polypeptide-relate...
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-73712-1 |
| _version_ | 1850351790455783424 |
|---|---|
| author | Hitoshi Toyoda Atsuo Kuramasu Masahiro Hosonuma Masakazu Murayama Yoichiro Narikawa Junya Isobe Yuta Baba Kohei Tajima Eiji Funayama Midori Shida Yuki Maruyama Aya Sasaki Yuya Hirasawa Toshiaki Tsurui Hirotsugu Ariizumi Tomoyuki Ishiguro Risako Suzuki Sei Kobayashi Atsushi Horiike Noriko Hida Takehiko Sambe Koji Nobe Satoshi Wada Hitome Kobayashi Mayumi Tsuji Shinichi Kobayashi Takuya Tsunoda Yoshifumi Kudo Yuji Kiuchi Kiyoshi Yoshimura |
| author_facet | Hitoshi Toyoda Atsuo Kuramasu Masahiro Hosonuma Masakazu Murayama Yoichiro Narikawa Junya Isobe Yuta Baba Kohei Tajima Eiji Funayama Midori Shida Yuki Maruyama Aya Sasaki Yuya Hirasawa Toshiaki Tsurui Hirotsugu Ariizumi Tomoyuki Ishiguro Risako Suzuki Sei Kobayashi Atsushi Horiike Noriko Hida Takehiko Sambe Koji Nobe Satoshi Wada Hitome Kobayashi Mayumi Tsuji Shinichi Kobayashi Takuya Tsunoda Yoshifumi Kudo Yuji Kiuchi Kiyoshi Yoshimura |
| author_sort | Hitoshi Toyoda |
| collection | DOAJ |
| container_title | Scientific Reports |
| description | Abstract Natural killer group 2 member D ligands (NKG2DLs) are expressed as stress response proteins in cancer cells. NKG2DLs induce immune cell activation or tumor escape responses, depending on their expression. Human pancreatic cancer cells, PANC-1, express membrane MHC class I polypeptide-related sequence A/B (mMICA/B), whereas soluble MICB (sMICB) is detected in the culture supernatant. We hypothesized that sMICB saturates NKG2D in NKG2DLow T cells and inhibits the activation signal from mMICB to NKG2D. Knockdown of MICB by siRNA reduced sMICB level, downregulated mMICB expression, maintained NKG2DLow T cell activation, and inhibited NKG2DHigh T cell activation. To maintain mMICB expression and downregulate sMICB expression, we inhibited a disintegrin and metalloproteinase (ADAM), a metalloproteinase that sheds MICB. Subsequently, the shedding of MICB was prevented using ADAM17 inhibitors, and the activation of NKG2DLow T cells was maintained. In vivo xenograft model revealed that NKG2DHigh T cells have superior anti-tumor activity. These results elucidate the mechanism of immune escape via sMICB and show potential for the activation of NKG2DLow T cells within the tumor microenvironment. |
| format | Article |
| id | doaj-art-9cc18d13b98e4eae855bec63d4c5642c |
| institution | Directory of Open Access Journals |
| issn | 2045-2322 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| spelling | doaj-art-9cc18d13b98e4eae855bec63d4c5642c2025-08-19T23:09:11ZengNature PortfolioScientific Reports2045-23222024-10-0114111210.1038/s41598-024-73712-1MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cellsHitoshi Toyoda0Atsuo Kuramasu1Masahiro Hosonuma2Masakazu Murayama3Yoichiro Narikawa4Junya Isobe5Yuta Baba6Kohei Tajima7Eiji Funayama8Midori Shida9Yuki Maruyama10Aya Sasaki11Yuya Hirasawa12Toshiaki Tsurui13Hirotsugu Ariizumi14Tomoyuki Ishiguro15Risako Suzuki16Sei Kobayashi17Atsushi Horiike18Noriko Hida19Takehiko Sambe20Koji Nobe21Satoshi Wada22Hitome Kobayashi23Mayumi Tsuji24Shinichi Kobayashi25Takuya Tsunoda26Yoshifumi Kudo27Yuji Kiuchi28Kiyoshi Yoshimura29Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Hospital Pharmaceutics, Showa University School of PharmacyDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDepartment of Otorhinolaryngology, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Clinical Pharmacology, Department of Pharmacology, Showa University School of MedicineDivision of Clinical Research and Development, Department of Clinical Pharmacy, School of Pharmacy, Showa UniversityPharmacological Research Center, Showa UniversityDepartment of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Otorhinolaryngology, Showa University School of MedicinePharmacological Research Center, Showa UniversityClinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDepartment of Orthopedic Surgery, Showa University School of MedicineDepartment of Pharmacology, Showa University School of MedicineDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityAbstract Natural killer group 2 member D ligands (NKG2DLs) are expressed as stress response proteins in cancer cells. NKG2DLs induce immune cell activation or tumor escape responses, depending on their expression. Human pancreatic cancer cells, PANC-1, express membrane MHC class I polypeptide-related sequence A/B (mMICA/B), whereas soluble MICB (sMICB) is detected in the culture supernatant. We hypothesized that sMICB saturates NKG2D in NKG2DLow T cells and inhibits the activation signal from mMICB to NKG2D. Knockdown of MICB by siRNA reduced sMICB level, downregulated mMICB expression, maintained NKG2DLow T cell activation, and inhibited NKG2DHigh T cell activation. To maintain mMICB expression and downregulate sMICB expression, we inhibited a disintegrin and metalloproteinase (ADAM), a metalloproteinase that sheds MICB. Subsequently, the shedding of MICB was prevented using ADAM17 inhibitors, and the activation of NKG2DLow T cells was maintained. In vivo xenograft model revealed that NKG2DHigh T cells have superior anti-tumor activity. These results elucidate the mechanism of immune escape via sMICB and show potential for the activation of NKG2DLow T cells within the tumor microenvironment.https://doi.org/10.1038/s41598-024-73712-1NKG2DLNKG2DT cellMICBADAMPancreatic tumor |
| spellingShingle | Hitoshi Toyoda Atsuo Kuramasu Masahiro Hosonuma Masakazu Murayama Yoichiro Narikawa Junya Isobe Yuta Baba Kohei Tajima Eiji Funayama Midori Shida Yuki Maruyama Aya Sasaki Yuya Hirasawa Toshiaki Tsurui Hirotsugu Ariizumi Tomoyuki Ishiguro Risako Suzuki Sei Kobayashi Atsushi Horiike Noriko Hida Takehiko Sambe Koji Nobe Satoshi Wada Hitome Kobayashi Mayumi Tsuji Shinichi Kobayashi Takuya Tsunoda Yoshifumi Kudo Yuji Kiuchi Kiyoshi Yoshimura MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells NKG2DL NKG2D T cell MICB ADAM Pancreatic tumor |
| title | MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells |
| title_full | MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells |
| title_fullStr | MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells |
| title_full_unstemmed | MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells |
| title_short | MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells |
| title_sort | mhc class i polypeptide related sequence b shedding modulates pancreatic tumor immunity via the activation of nkg2dlow t cells |
| topic | NKG2DL NKG2D T cell MICB ADAM Pancreatic tumor |
| url | https://doi.org/10.1038/s41598-024-73712-1 |
| work_keys_str_mv | AT hitoshitoyoda mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT atsuokuramasu mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT masahirohosonuma mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT masakazumurayama mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT yoichironarikawa mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT junyaisobe mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT yutababa mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT koheitajima mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT eijifunayama mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT midorishida mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT yukimaruyama mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT ayasasaki mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT yuyahirasawa mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT toshiakitsurui mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT hirotsuguariizumi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT tomoyukiishiguro mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT risakosuzuki mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT seikobayashi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT atsushihoriike mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT norikohida mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT takehikosambe mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT kojinobe mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT satoshiwada mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT hitomekobayashi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT mayumitsuji mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT shinichikobayashi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT takuyatsunoda mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT yoshifumikudo mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT yujikiuchi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells AT kiyoshiyoshimura mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells |
